Withdrawal of clinical trials policy by Canadian research institute is a “lost opportunity for increased transparency”

No abstract is available for this paper.

• Publication year

  2011

• Venue

  British medical journal

• Publication date

  2011-04-21

• Fields of study

  Medicine, Political Science

• Identifiers
  DOI 10.1136/bmj.d2570PMID 21511787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Four disruptive strategies for removing drug discovery bottlenecks.

  2013cites this paper
• Unfinished Business: Ongoing Ethical Exceptionalism in the Oversight of Human Pluripotent Stem Cell Research in Canada

  2012cites this paper
• Unlocking Health Canada’s cache of trade secrets: mandatory disclosure of clinical trial results

  2012cites this paper